Alterola Biotech, Inc. (ABTI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT
Alterola Biotech Market Cap
Alterola Biotech has a market cap or net worth of $296.25 million as of July 16, 2025. Its market cap has increased by 424.40% in one year.
Market Cap
296.25M
Enterprise Value
298.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 21, 2021, Alterola Biotech's market cap has decreased from 1.46B to 296.25M, a decrease of -79.65%. That is a compound annual growth rate of -32.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 296.25M | 6,666.08% |
| Dec 24, 2024 | 4.38M | -10.93% |
| Dec 19, 2023 | 4.92M | -87.82% |
| Dec 30, 2022 | 40.35M | -63.75% |
| Dec 31, 2021 | 111.33M | -92.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 840.66M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 567.50M |
| Nika Pharmaceuticals | 554.26M |
| Glass House Brands | 416.87M |
| CytoDyn | 386.96M |
| Northwest Biotherapeutics | 384.78M |